LARIO THERAPEUTICS Trademark

Trademark Overview


On Thursday, July 14, 2022, a trademark application was filed for LARIO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LARIO THERAPEUTICS trademark a serial number of 97503907. The federal status of this trademark filing is REINSTATED - AWAITING FURTHER ACTION as of Monday, December 2, 2024. This trademark is owned by Lario Therapeutics Ltd. The LARIO THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of neurological conditions; veterinary preparations for the treatment of neurological disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of neurological disorders; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of neuro-degenerative diseases; pharmaceutical preparations for the treatment of Parkinson's disease

Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services

Research, development, evaluation and design services in the fields of medical, biological, biotechnological, genetic, laboratory and pharmaceutical and veterinary preparations and medications; research, development and design of drugs and medicine, veterinary preparations, laboratory and medical laboratory research and development services; research, development, evaluation and design services in relation to neurological disorders; research, development, evaluation and design services in relation to central nervous system disorders; research, development, evaluation and design services in relation to neuro-degenerative diseases; research, development, evaluation and design services in relation to Parkinson's Disease; exploitation of scientific research and technology, namely, providing information relating to scientific and technological research in the fields of drugs, pharmaceuticals and medicines in the nature of reports; development of prognostic and diagnostic tools; consultancy ...

General Information


Serial Number97503907
Word MarkLARIO THERAPEUTICS
Filing DateThursday, July 14, 2022
Status672 - REINSTATED - AWAITING FURTHER ACTION
Status DateMonday, December 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological conditions; veterinary preparations for the treatment of neurological disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of neurological disorders; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of neuro-degenerative diseases; pharmaceutical preparations for the treatment of Parkinson's disease
Goods and ServicesMedical consultation services featuring preparation of reports relating to medical and pharmaceutical services
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch, development, evaluation and design services in the fields of medical, biological, biotechnological, genetic, laboratory and pharmaceutical and veterinary preparations and medications; research, development and design of drugs and medicine, veterinary preparations, laboratory and medical laboratory research and development services; research, development, evaluation and design services in relation to neurological disorders; research, development, evaluation and design services in relation to central nervous system disorders; research, development, evaluation and design services in relation to neuro-degenerative diseases; research, development, evaluation and design services in relation to Parkinson's Disease; exploitation of scientific research and technology, namely, providing information relating to scientific and technological research in the fields of drugs, pharmaceuticals and medicines in the nature of reports; development of prognostic and diagnostic tools; consultancy and information services relating to all of the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 21, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 21, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLario Therapeutics Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEdinburgh EH24JY
GB

Party NameLario Therapeutics Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdinburgh EH24JY
GB

Trademark Events


Event DateEvent Description
Monday, July 18, 2022NEW APPLICATION ENTERED
Thursday, August 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 28, 2023ASSIGNED TO EXAMINER
Tuesday, May 30, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 30, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 11, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, August 11, 2023EXAMINERS AMENDMENT E-MAILED
Friday, August 11, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 11, 2023EXAMINER'S AMENDMENT ENTERED
Friday, August 11, 2023SUSPENSION LETTER WRITTEN
Friday, August 11, 2023LETTER OF SUSPENSION E-MAILED
Friday, August 11, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 18, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 11, 2024ASSIGNED TO LIE
Thursday, January 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 23, 2024TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU EXTENSION 1 FILED
Tuesday, October 29, 2024SOU EXTENSION 1 GRANTED
Monday, December 2, 2024TEAS REQUEST FOR REINSTATEMENT
Monday, December 2, 2024REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED